Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) is a homegrown Canadian company producing natural, scalable and accessible psychedelic and functional mushrooms and synthetic formulations for transformational human experiences. The company is on Health Canada’s list of approved suppliers under the Special Access Program (SAP), which allows medical practitioners access to Schedule 3 controlled substances like psilocybin on a case-by-case emergency basis.
On September 7, Optimi Health (CSE:OPTI) (OTCQX:OPTHF) announced that it has signed a contract with privately held UK-based Avida Global, a producer of premium wellness products, including nutraceuticals and therapeutic cannabis oils, for the international wellness and ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap . Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here .
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer .
For further details see:
Optimi Health and Avida Global Sign First International Mushroom Supply Agreement